Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,500 public trials 2,843 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

Long-term Safety and Efficacy Study and Dose-Escalation Substudy of PF 06838435 in Individuals With Hemophilia B

NCT03307980

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • UC Davis Ellison Ambulatory Care Clinic Sacramento, California, United States
  • UC Davis Medical Center department of Radiology Sacramento, California, United States
  • UC Davis Medical Center Sacramento, California, United States
View all 25 locations
View Trial Details
Completed

A Study of Evaluating the Safety and Efficacy of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)

NCT04939142

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • The First Affiliated Hospital OF USTC Hefei, Anhui, China
  • The First Affiliated Hospital of Wannan Medical College Wuhu, Anhui, China
  • Beijing Chao-Yang Hospital Beijing, Beijing Municipality, China
View all 33 locations
View Trial Details
Completed

A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia

NCT03025698

Conditions
Anemia, Anemia, Aplastic, Aplastic Anemia, +4 more
Locations
  • Arkansas Childrens Hospital Little Rock, Arkansas, United States
  • Childrens Hospital Colorado Aurora, Colorado, United States
  • Aflac Cancerand Blood Disorders Ctr Atlanta, Georgia, United States
  • Indiana University Indianapolis, Indiana, United States
View all 20 locations
View Trial Details
Completed

Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy

NCT04889430

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
Locations
  • USC Norris Cancer Center Los Angeles, California, United States
  • Univ of California at Los Angeles Los Angeles, California, United States
  • Univ Cali Irvine ALS Neuromuscular Orange, California, United States
  • Univ of California at Sacramento Sacramento, California, United States
View all 36 locations
View Trial Details

Related conditions